Evidence map›Paper›PMID 42599993›Full record

ArticleScience advances2026

Lineage master regulator and cancer-selective partner transcription factors rewire 3D genome topology for tumor-specific gene control.

Namyoung Jung, Vanessa Lopez-Pajares, Laura K H Donohue, Margaret G Guo, Suhas Srinivasan, Zurab Siprashvili, Paul A Khavari

Abstract read
In one paragraph

Article in Science advances, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Namyoung JungProgram in Epithelial Biology, Stanford University School of Medicine, Stanford, CA, USA.ORCID 0000-0003-0027-5330
Vanessa Lopez-PajaresProgram in Epithelial Biology, Stanford University School of Medicine, Stanford, CA, USA.ORCID 0000-0001-8538-344X
Laura K H DonohueProgram in Epithelial Biology, Stanford University School of Medicine, Stanford, CA, USA.ORCID 0000-0002-1346-2840
Margaret G GuoProgram in Epithelial Biology, Stanford University School of Medicine, Stanford, CA, USA.ORCID 0000-0001-7713-3846
Suhas SrinivasanProgram in Epithelial Biology, Stanford University School of Medicine, Stanford, CA, USA.ORCID 0000-0001-8309-9648
Zurab SiprashviliProgram in Epithelial Biology, Stanford University School of Medicine, Stanford, CA, USA.
Paul A KhavariProgram in Epithelial Biology, Stanford University School of Medicine, Stanford, CA, USA.ORCID 0000-0003-0098-4989

Funding

Translational Oncology Research Program (Project-005)P30CA124435 · NCI · STANFORD UNIVERSITY · PI MICHAEL KENNEY · 2007 to 2026
$71.4M
REGULATORS OF EPIDERMAL GENE EXPRESSIONR01AR045192 · NIAMS · STANFORD UNIVERSITY · PI PAUL KHAVARI · 1999 to 2026
$9.9M
Mechanisms of Epidermal Homeostasis and Early NeoplasiaR01AR043799 · NIAMS · STANFORD UNIVERSITY · PI PAUL KHAVARI · 1998 to 2026
$9.1M
Signaling Regulators of Epithelial Homeostasis and NeoplasiaR01AR049737 · NIAMS · STANFORD UNIVERSITY · PI PAUL KHAVARI · 2004 to 2026
$7.1M
Transcriptional Regulatory Complexes in Epidermal DifferentiationK01AR070895 · NIAMS · STANFORD UNIVERSITY · PI LOPEZPAJARES, VANESSA · 2017 to 2022
$709k
BLRD VA I01 BX001409NCI NIH HHS P30 CA124435NIAMS NIH HHS K01 AR070895NIAMS NIH HHS R01 AR043799NIAMS NIH HHS R01 AR045192NIAMS NIH HHS R01 AR049737
6 · The paper itself

Abstract

Lineage-determining transcription factors (TFs), such as p63 in epithelial tissues, establish normal tissue identity but can also drive carcinogenesis. The epigenetic basis for these divergent effects, however, is unclear. Here, we show that p63 reorganizes three-dimensional (3D) chromatin topology in squamous cell carcinoma (SCC) through cooperation with the tumor-selective partner TF, FOXK1. Multi-omic profiling across normal and malignant states reveals that p63 enhances connectivity between cis-regulatory elements near oncogenes and promotes a secondary enhancer looping architecture, in which p63 and FOXK1-enriched enhancers indirectly contact target promoters via FOXK1-associated intermediate anchors lacking p63 binding. FOXK1 mediates p63-dependent chromatin looping, as FOXK1 loss selectively weakens p63-dependent loops and reduces transcription of associated target genes. The p63-FOXK1 interaction is observed in human tumor samples but not in normal tissues. Together, our findings define an epigenetic mechanism by which a lineage master TF and tumor-restricted partner TF reshape 3D chromatin structure to drive oncogenic transcription, with implications for tumor cell identity and therapy.

Indexed as

Carcinoma, Squamous CellForkhead Transcription FactorsGene Expression Regulation, NeoplasticTranscription FactorsTumor Suppressor ProteinsCell Line, TumorChromatinEnhancer Elements, GeneticEpigenesis, GeneticHumansPromoter Regions, GeneticChromatinForkhead Transcription FactorsTP63 protein, humanTranscription FactorsTumor Suppressor Proteins

Identifiers

PMID42599993
PMCPMC13475494

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.